FASLG and cancer: The proteolytically cleaved sFasL has been shown to be an inducer of apoptosis, although it is less active than the membrane-bound FasL [26]; therefore, elevated serum levels of sFasL in cancer patients [27,28,29] may represent an additional mechanism of immune escape [30,31].